The screening for PBC-related autoantibodies (i.e., AMA and ANA) is conventionally performed, especially in European countries, using IIF instead of solid-phase test systems (i.e., ELISA and immunodot assays). This evidence concerns the gene BTG3 and primary biliary cholangitis.